Lentiviral Vectors Market

Lentiviral Vectors Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: May 2026 | Format: | No. of Pages: 200

Industry: Healthcare IT | Author Name: Sayali

Request Sample / Information

The market is anticipated to be valued at USD 1 Bn by 2033.

Lentiviral vectors are used for early gene therapy trials for human disease.

The market is projected to exhibit a growth rate 5% over the forecast period.

Takara Bio, Inc., Charles River Laboratories, Sino Biological Inc., are some of the key industry players in the market.

Expansion of gene editing applications provides a key opportunity for the market players.

Quality assured

Confidentiality assured

Custom research services